Morphea

11 registered clinical trials studyying Morphea — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases NCT04922736	University of Utah	N/A
Completed	The Influence of Extracorporeal Photopheresis on Skin Sclerosis NCT04752397	Charite University, Berlin, Germany	—
Withdrawn	Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease NCT04656704	Brigham and Women's Hospital	EARLY_Phase 1
Terminated	A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea) NCT03740724	Castle Creek Biosciences, LLC.	Phase 1 / Phase 2
Completed	Pain Outcomes Following Intralesional Corticosteroid Injections NCT03630198	Vanderbilt University Medical Center	Phase 4
Completed	Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea NCT03351114	Duke University	Phase 2
Terminated	Molecular Effects of Topical Calcipotriene on Morphea NCT02411643	Northwestern University	EARLY_Phase 1
Completed	Genetic Variants in Linear Localized Scleroderma NCT02222038	University Children's Hospital, Zurich	N/A
Completed	Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea NCT01799174	University of Texas Southwestern Medical Center	N/A
Recruiting	Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository NCT01808937	University of Texas Southwestern Medical Center	—
Withdrawn	Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study NCT00230373	University of Alberta	Phase 3